Assessment of Serum Interleukin-19 Level in Patients with Diabetic Nephropathy
Mariam A. Atiia *
Department of Internal medicine, Nephrology, El-Mahalla Hospital, Ministry of Health, Egypt.
Yasser M. Hafez
Department of Internal Medicine, Tanta University, Tanta, Egypt.
Maaly M. Mabrouk
Department of Clinical pathology, Faculty of Medicine, Tanta University, Egypt.
Medhat A. Ghazy
Department of Internal Medicine, Tanta University, Tanta, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Background: Interleukin-19 (IL-19) is a newly discovered cytokine belonging to the Interleukin-10 (IL-10) family. IL-19 has indispensable functions in many inflammatory processes and also can induce the angiogenic potential of endothelial cells. The purpose of present study was to assess the level of serum interleukin-19 (IL-19) in patients with diabetic nephropathy (DN).
Our Study Aimed to assess the level of serum IL-19 in patients with diabetic nephropathy.
Methods: In this cross-sectional study, we tested 90 subjects; 30 healthy control and 60 diabetic nephropathy patients recruited from outpatient clinics and wards of Internal Medicine department, Tanta university hospitals, Egypt. Patients were subdivided into 3subgroup according to the urinary albumin creatinine ratio (ACR).
Results: The serum IL-19 levels in DN patients were significantly higher than the control group. The mean serum IL-19 level was 15.45±4.34 Pg/ml, 32.66±8.05 Pg/ml, 56.03±7.89 Pg/ml and 71.41±12.37 Pg/ml dL for control, normoalbuminuria group, microalbuminuria group and macroalbuminuria group respectively.
Conclusions: Serum IL-19 level was significantly elevated in patients with diabetic nephropathy and was associated with the marker of inflammation CRP (C -reactive protein). So
Keywords: Interleukin-19, diabetic nephropathy, urinary albumin creatinine ratio, C -reactive protein